Major shareholder fails to reduce stake in Zhejiang Medicine

Zhejiang Medicine announced that Guotou High-Tech Investment, a shareholder holding over 5% of the company's shares, did not execute its previously announced share reduction plan. The original plan, disclosed on March 21, 2025, intended to reduce holdings by no more than 9,616,377 shares, or 1% of the total share capital, through centralized bidding. However, the reduction period concluded on July 9, 2025, with no shares being sold. Guotou High-Tech Investment currently holds 150,127,573 shares, representing 15.61% of Zhejiang Medicine's total equity. The company confirmed that the actual reduction situation aligns with the previously disclosed plan and that there was no implementation of the reduction.